-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) Reiterated at Market Outperform by Citizens
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $105 at H.C. Wainwright
-
-
-
-
-
-
-
Stifel says Buy rated on Rhythm Pharmaceuticals (RYTM) despite EMANATE failure
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $140 at Guggenheim
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $145 at Needham
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $110 at H.C. Wainwright
-
427,073 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

